ArticleOpen medicine (Warsaw, Poland)2026
Effect of navigated transcranial magnetic stimulation for glioma surgery outcomes: a systematic review and meta-analysis.
Article in Open medicine (Warsaw, Poland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Gliomas are the most common primary brain tumors in adults, often linked to poor prognosis despite advances in treatment. Navigated transcranial magnetic stimulation (nTMS) is a non-invasive preoperative mapping technique that may improve glioma surgery outcomes by enhancing tumor resection and preserving neurological function. This meta-analysis evaluates the impact of nTMS on glioma resection outcomes. Methods: A literature search was conducted in PubMed, Embase, Cochrane Library, and Web of Science up to September 2024 for cohort or case-control studies comparing nTMS-guided surgery with conventional planning, with or without subcortical fibre-guided tractography (SFG) and intra-operative neurophysiological monitoring (IONM). Data on extent of resection, motor function, quality of life (Karnofsky Performance Status), and complications were extracted. Statistical analysis was performed using RevMan 5.3. This study was registered at PROSPERO (registration number CRD42025641788). Results: Five studies with 736 patients were included. The nTMS group showed significantly higher rates of gross total resection (GTR) and lower rates of subtotal resection (STR) compared to the non-nTMS group. No significant differences were found in postoperative motor function or quality of life. Two studies comparing nTMS + SFG + IONM with IONM alone demonstrated higher GTR rates (absolute increase 12-18 %) and reduced permanent motor paresis (3-6 % vs. 9-14 %); one reached statistical significance for neurological outcomes. Conclusions: Pre-operative nTMS significantly improves the anatomical radicality of glioma resection without increasing early neurological morbidity. Integration of nTMS with SFG-based tractography and IONM may confer additional functional protection, highlighting the value of a multimodal mapping strategy for tumors abutting motor-eloquent cortex. Further studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.